Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
68,794
Employees68,794
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
68,794
Employees68,794

NVO Key Statistics

Market cap
200.95B
Market cap200.95B
Price-Earnings ratio
11.02
Price-Earnings ratio11.02
Dividend yield
2.73%
Dividend yield2.73%
Average volume
10.18M
Average volume10.18M
High today
$45.40
High today$45.40
Low today
$44.72
Low today$44.72
Open price
$45.03
Open price$45.03
Volume
4.61M
Volume4.61M
52 Week high
$64.16
52 Week high$64.16
52 Week low
$35.12
52 Week low$35.12

NVO News

TipRanks 1h
Novo Nordisk Advances Oral Semaglutide Trial in Obesity: What Investors Should Watch

Novo Nordisk (NVO) announced an update on their ongoing clinical study. Novo Nordisk’s new Phase 3 trial, “Efficacy and Safety of Once Daily Oral Semaglutide i...

TipRanks 7h
Novo Nordisk Advances DKK 15 Billion Share Buyback, Holding 1% of Capital in Treasury Stock

An announcement from Novo Nordisk ( (NVO) ) is now available. Novo Nordisk has continued executing its previously announced share repurchase programme, which f...

Simply Wall St 21h
Novo Nordisk (CPSE:NOVO B) Stock Looks Cheap Even As Caution Lingers - simplywall.st

...

Novo Nordisk (CPSE:NOVO B) Stock Looks Cheap Even As Caution Lingers - simplywall.st

More NVO News

Nasdaq 1d
Is Novo Nordisk Stock Still Too Cheap for Investors to Ignore?

Key Points Novo Nordisk was first to market with a GLP-1 weight-loss drug, but lost the lead to Eli Lilly. Novo Nordisk has been working hard to regain lost m...

Is Novo Nordisk Stock Still Too Cheap for Investors to Ignore?
Seeking Alpha 1d
Novo Nordisk faces fresh setback as it halts two heart drug trials

Novo Nordisk (NVO) has halted two late-stage trials of its experimental heart drug ziltivekimab, adding to the drugmaker’s recent pipeline setbacks. The Danish...

Novo Nordisk faces fresh setback as it halts two heart drug trials
TipRanks 2d
Novo Nordisk halts two trials testing ziltivekimab, Bloomberg reports

Novo Nordisk (NVO) has halted two trials testing if ziltivekimab, its experimental heart disease medicine, would help patients with heart failure, Ashleigh Furl...

TipRanks 2d
Novo Nordisk announces STEP Young phase 3 trial met its primary endpoint

Novo Nordisk (NVO) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination with a reduced-calorie diet and...

TipRanks 2d
Novo Nordisk Hit by Another Heart Drug Setback

Novo Nordisk (NVO) has halted two late‑stage studies of its experimental heart drug ziltivekimab, marking a major setback in its push into cardiovascular medici...

Nasdaq 2d
Novo Nordisk: STEP Young Phase 3 Trial With Semaglutide Shows Superior BMI Reduction At Week 68

(RTTNews) - Novo Nordisk (NVO, NOVOB.CO, NOV.DE) announced first results from the STEP Young phase 3 trial, evaluating once-weekly semaglutide in combination wi...

Novo Nordisk: STEP Young Phase 3 Trial With Semaglutide Shows Superior BMI Reduction At Week 68
The Wall Street Journal 2d
Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial

Overall safety and tolerability of the drug were consistent with previous trials in children and adults. Shelby Knowles / Bloomberg Novo Nordisk NOVO.B -0.13 %...

Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.